Foslevodopa-Foscarbidopa (Vyalev)

[bcjlynne]

Sign of a new delivery system for levodopa coming down the pike?

or potential to replace DBS?

canjhealthtechnol.ca/index....

[park_bear]

fiercepharma.com/pharma/abb...

US approval delayed to 2024

ncbi.nlm.nih.gov/books/NBK5...

[US] "Treatment with Vyalev is expected to have an annual cost of $62,023 per patient assuming patients will use approximately 1 vial per day. "

Extortionate in my opinion for something that provides a more even flow of levodopa.

[parkie13 in reply to park_bear]

I don't think that medicare cares about me that much.